))
Diabetes Monitoring: Human out of the loop
Manage episode 353523918 series 3436789
Innehåll tillhandahållet av TTP plc. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av TTP plc eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
In this first episode of Invent:Health Season 2, Matt Parker speaks to Chris Dawson, Head of Biosensing at TTP, and Dr. Andrew Chapman, CEO, and Co-Founder of Carbometrics, to explore how patients can be taken out of this monitoring-delivery loop and what technologies are out there that can automate the process entirely.
This Week's Guests
Chris Dawson - Dr. Chris Dawson is a mechanical engineer who leads the biosensing team at TTP. The team works with clients to leverage advances in biosensing technology to develop products that support patients in managing and treating a wide range of diseases. They develop sensing solutions from short-term minimally invasive to long-term fully implantable, all with challenging requirements for biocompatibility, hermeticity, form-factor, wireless power & comms, and integrate a broad range of sensing modalities from electrical and electrochemical, through to ultrasonic and optical.
Andrew Chapman - Dr. Andrew Chapman is a scientist and entrepreneur who for over a decade, has designed and led interdisciplinary commercial and academic programs across a whole range of different scientific disciplines. Andrew is currently the CEO and co-founder of Carbometrics, a company whose revolutionary biomimetic glucose binding molecules have made them one of the most exciting companies working in this space.
The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: www.ttp.com
19 episoder
Dela
